GDM was associated with subclinical inflammation, and affected women showed increased plasma leptin and lower plasma adiponectin levels independently of the degree of insulin sensitivity or obesity [36]. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.